RCKT Stock Earnings: Rocket Pharmaceuticals Beats EPS for Q1 2024

    Date:

    Rocket Pharmaceuticals (NASDAQ:RCKT) just reported results for the first quarter of 2024.

    • Rocket Pharmaceuticals reported earnings per share of -66 cents. This was above the analyst estimate for EPS of -69 cents.
    • The company did not report any revenue for the quarter.

    InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

    Go Source

    Chart

    SignUp For Breaking Alerts

    New Graphic

    We respect your email privacy

    Share post:

    Popular

    More like this
    Related

    Two Years in a Row With Gains Over 20%: Dec. 31, 2024

    Your Privacy When you visit any website it may use...

    25 Years Ago Today, Many of Us Were Terrified

    It seems like a quaint anachronism now, but Y2K...

    Gap Trading Strategy: Based on the Markov Rule | EPAT Project

    The post “Gap Trading Strategy: Based on the Markov...

    Charged: Analysts see Tesla Q4 deliveries missing consensus expectations

    UBS and GLJ Research both expect Tesla to report...